Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion | Revista Colombiana de Reumatología (English Edition)

ISSN: 2444-4405

The Colombian Journal of Rheumatology (Revista Colombiana de Reumatología) is the official organ of the Colombian Association of Rheumatology (Asociación Colombiana de Reumatología) and the Central American, Caribbean and Andean Association of Rheumatology (Asociación Centroamericana Caribe Andina de Reumatología) - ACCAR. It was created in December 1993 with the purpose of disseminating scientific information derived from primary and secondary research and presenting cases coming from the practice of Rheumatology in Latin America. Since its foundation, the Journal has been characterized by its plurality with subjects of all rheumatic and osteomuscular pathologies, in the form of original articles, historical articles, economic evaluations, and articles of reflection and education in Medicine. It covers an extensive area of topics ranging from the broad spectrum of the clinical aspects of rheumatology and related areas in autoimmunity (both in pediatric and adult pathologies), to aspects of basic sciences. It is an academic tool for the different members of the academic and scientific community at their different levels of training, from undergraduate to post-doctoral degrees, managing to integrate all actors inter-and transdisciplinarily. It is intended for rheumatologists, general internists, specialists in related areas, and general practitioners in the country and abroad. It has become an important space in the work of all rheumatologists from Central and South America.

See more Open Access Option

Indexed in:

Scopus, SciELO, Latindex, Imbiomed, Lilacs, e-revist@s, Periódica and Embase.

, Oscar-Jair Felipe-Díaza, Wilmer-Gerardo Rojas-Zuletaa, Jesús-Giovanny Ballesterosa, Erika-Paola Navarro-Mendozaa, Claudia-Lucía Giraldo Herreraa, Rodrigo Giraldo-Bustosa, Lácides Padilla-Tovara, Natalia Duque-Zapatab, Catalina Orozco Gonzálezb, María-José López-Morac, Jorge-Hernando Donadob

a Reumatología, Grupo de Investigación Medicarte (GIM), Medicarte, Bogotá, Colombia

b Epidemiología, Grupo de Investigación Medicarte (GIM), Medicarte, Bogotá, Colombia

c Infectóloga, Hospital Universitario San Ignacio, Bogotá, Colombia

This item has received

1634 Visits

Received 03 April 2020. Accepted 19 May 2020

Article information

Abstract

Full Text

Bibliography

Download PDF

Statistics

Abstract

Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, and other systemic autoimmune diseases have been described for its treatment. Therefore, there is an imminent risk of shortages. The aim of this narrative review and expert opinion is to present general recommendations on the clinical and administrative management of outpatients with autoimmune or systemic inflammatory disease, in the context of the COVID-19 pandemic.

Keywords:

Rheumatology

COVID-19

Coronavirus

Antimalarials

Drug therapy

Resumen

La enfermedad por Coronavirus 2019 (COVID-19) es una pandemia inesperada que ha provocado un estado de emergencia y que ha generado cambios drásticos en los protocolos de atención clínica. Para su tratamiento se ha descrito el papel de algunos medicamentos usados habitualmente en artritis reumatoide, lupus eritematoso sistémico y otras enfermedades autoinmunitarias sistémicas. Debido a ello, existe un inminente riesgo de desabastecimiento, por lo cual el objetivo de esta revisión narrativa y opinión de expertos es formular recomendaciones generales clínicas y administrativas sobre el manejo de pacientes ambulatorios con enfermedad autoinmunitaria o inflamatoria sistémica en el contexto de la pandemia por COVID-19.

Palabras clave:

Reumatología

COVID-19

Coronavirus

Antimaláricos

Terapia con medicamentos